- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 215.82M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2025 | 206.81M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2025 | 204.76M sh |
| Shares Diluted restated | Q3 2025 · Sep 29, 2024 | 187.98M sh |
| Shares Diluted restated | Q3 2025 · Sep 29, 2024 | 183.23M sh |
| Stock Repurchased | Q3 2025 · Sep 28, 2025 | $58.39M |
| Stock Repurchased restated | Q3 2025 · Sep 29, 2024 | $0 |
| Capex | Q3 2025 · Sep 28, 2025 | $17.22M |
| Capex | Q3 2025 · Sep 29, 2024 | $59.83M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2025 | −$68.29M |
| Operating Cash Flow | Q3 2025 · Sep 29, 2024 | −$92.68M |
| Long Term Debt | Q3 2025 · Sep 28, 2025 | $518.35M |
| Long Term Debt | Q3 2025 · Dec 29, 2024 | $169.82M |
| Short Term Debt | Q3 2025 · Sep 28, 2025 | $9.9M |
| Short Term Debt | Q3 2025 · Dec 29, 2024 | $9.3M |
| Short Term Investments | Q3 2025 · Sep 28, 2025 | $223.32M |
| Short Term Investments | Q3 2025 · Dec 29, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 28, 2025 | $335.5M |
| Cash And Equivalents | Q3 2025 · Dec 29, 2024 | $272.87M |
| Cash And Equivalents | Q3 2025 · Sep 29, 2024 | $200.91M |
| Stockholders Equity | Q3 2025 · Sep 28, 2025 | $294.26M |
| Stockholders Equity | Q3 2025 · Dec 29, 2024 | $246.74M |
| Current Liabilities | Q3 2025 · Sep 28, 2025 | $60.57M |
| Current Liabilities | Q3 2025 · Dec 29, 2024 | $53.7M |
| Total Liabilities | Q3 2025 · Sep 28, 2025 | $616.61M |
| Total Liabilities | Q3 2025 · Dec 29, 2024 | $277.77M |
| Current Assets | Q3 2025 · Sep 28, 2025 | $588.63M |
| Current Assets | Q3 2025 · Dec 29, 2024 | $295.01M |
| Total Assets | Q3 2025 · Sep 28, 2025 | $913.71M |
| Total Assets | Q3 2025 · Dec 29, 2024 | $527.17M |
| Eps Diluted | Q3 2025 · Sep 28, 2025 | −$0.27 |
| Eps Diluted | Q3 2025 · Sep 28, 2025 | −$0.59 |
| Eps Diluted restated | Q3 2025 · Sep 29, 2024 | −$0.28 |
| Eps Diluted restated | Q3 2025 · Sep 29, 2024 | −$1.01 |
| Eps Basic | Q3 2025 · Sep 28, 2025 | −$0.26 |
| Eps Basic | Q3 2025 · Sep 28, 2025 | −$0.59 |
| Eps Basic restated | Q3 2025 · Sep 29, 2024 | −$0.12 |
| Eps Basic restated | Q3 2025 · Sep 29, 2024 | −$1.01 |
| Sga Expense | Q3 2025 · Sep 28, 2025 | $20.19M |
| Sga Expense | Q3 2025 · Sep 28, 2025 | $54.61M |
| Sga Expense | Q3 2025 · Sep 29, 2024 | $20.74M |
| Sga Expense | Q3 2025 · Sep 29, 2024 | $61.18M |
| Rd Expense | Q3 2025 · Sep 28, 2025 | $28.18M |
| Rd Expense | Q3 2025 · Sep 28, 2025 | $82.26M |
| Rd Expense | Q3 2025 · Sep 29, 2024 | $24.22M |
| Rd Expense | Q3 2025 · Sep 29, 2024 | $102.07M |
| Net Income | Q3 2025 · Sep 28, 2025 | −$53.71M |
| Net Income | Q3 2025 · Sep 28, 2025 | −$121.75M |
| Net Income | Q3 2025 · Sep 29, 2024 | −$22.54M |
| Net Income | Q3 2025 · Sep 29, 2024 | −$184.78M |
| Operating Income | Q3 2025 · Sep 28, 2025 | −$46.97M |
| Operating Income | Q3 2025 · Sep 28, 2025 | −$133.27M |
| Operating Income | Q3 2025 · Sep 29, 2024 | −$49.27M |
| Operating Income | Q3 2025 · Sep 29, 2024 | −$208.15M |
| Gross Profit | Q3 2025 · Sep 28, 2025 | $1.4M |
| Gross Profit | Q3 2025 · Sep 28, 2025 | $3.6M |
| Gross Profit | Q3 2025 · Sep 29, 2024 | −$642K |
| Gross Profit | Q3 2025 · Sep 29, 2024 | −$3.1M |
| Revenue | Q3 2025 · Sep 28, 2025 | $7.99M |
| Revenue | Q3 2025 · Sep 28, 2025 | $20.56M |
| Revenue | Q3 2025 · Sep 29, 2024 | $4.32M |
| Revenue | Q3 2025 · Sep 29, 2024 | $13.36M |